Prescriptions for the newest – but more expensive — cholesterol-lowering drugs called PCSK9 inhibitors that are not covered by insurance companies or unfilled by patients are related to higher risk of cardiovascular problems for high risk patients. High co-payments may make patients less likely to fill prescriptions, even if insurers approve them. Prescriptions written for women, blacks and Hispanics were more likely to be rejected.
Rejected and unfilled prescriptions for new, more expensive cholesterol drugs tied to higher heart, stroke risk
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024
About admin
Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge.
Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →